Physician profile
John Andrew Freeman
NPI 1144872920
$2,986.81
in general payments reported to CMS, 2019-2025
9 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what 96% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $108 · 2021: $15.00 · 2022: $133 · 2023: $1,330 · 2024: $335 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Gift: $1,006 · Travel and Lodging: $487 · Entertainment: $81.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.40 |
| Gift | $1,006.03 |
| Travel and Lodging | $486.80 |
| Entertainment | $81.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,021.56 | 2022-2025 | |
| Keystone Dental INC. | $584.18 | 2022-2024 | |
| Ultradent Products INC | $537.54 | 2024-2025 | Opalescence |
| A-Dec, INC. | $534.55 | 2025 | |
| Align Technology, INC. | $144.58 | 2020-2024 | Invisalign, Itero Element 5d |
| Dentsply Sirona INC | $100.00 | 2020 | |
| Biohorizons Implant Systems INC. | $37.35 | 2024 | Biohorizons |
| 3m Company | $15.00 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.